Point of Care (PoC) Molecular Diagnostics Market Size By Technology [Polymerase Chain Reaction (Real Time PCR, DNA/RNA Purification), In Situ Hybridization, Chips and Microarrays, Mass Spectrometry, Sequencing, Isothermal Amplification, Others], By Infectious Diseases (MRSA, Clostridium difficile, Vancomycin-resistant Enterococci, Carbapenem-Resistant Bacteria Testing, Flu, Respiratory Syncytial Virus, Candida, Tuberculosis and Drug-resistant TB, Meningitis, Gastro-intestinal Panel Testing, Chlamydia, Gonorrhea, HIV , Hepatitis C, Hepatitis B, HPV, Syphilis, Others), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Japan, China, India, South Korea, Malaysia, Thailand, Vietnam, Philippines, Australia, Brazil, Argentina, Mexico, South Africa, Nigeria, Egypt, Morocco, Saudi Arabia, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2017 - 2024

Choose License

Increasing awareness regarding pre-disease diagnosis along with growing incidence of infectious diseases will drive POC molecular diagnostics market growth. Growing R&D focused on reducing time required for molecular tests will further propel industry growth. However, long product development time and complex regulatory process will hamper the business acceleration. Global point of care (PoC) molecular diagnostics market is set to exceed USD 2.5 billion by 2024, according to this new research report.

Isothermal amplification technology should exhibit lucrative growth as they are used as an alternative to polymerase chain reaction. Thermocycling machines are not required in the use of this technology and it can mostly be performed with reduced time, greater accuracy and high throughput. The increased reliability of isothermal amplification will drive segment growth. The added benefit of constant temperature of amplification provides a high potential for simple integration of this technique in PoC devices.

Sequencing technology are poised to grow at the fastest pace as ongoing advancements and increase in sequencing throughput have considerably decreased both sequencing costs and time.

Point of care molecular diagnostics for Clostridium difficile will witness robust growth in the coming years. In the developed countries, Clostridium infection is the most common cause of nosocomial infectious diarrhea. Growing use of PoC test owing to feasibility, performance ease and acceptability will fuel demand.

Growing demand for accurate and inexpensive PoC tests for controlling sexually transmitted infections along with need for immediate patient diagnosis and treatment will drive point of care molecular diagnostics for Gonorrhea.

India point of care molecular diagnostics market is slated to experience rapid growth over the forecast years. Increasing burden of various infectious diseases such as HIV, Tuberculosis, Hepatitis and Influenza will stimulate demand. PoC diagnostic testing is at its nascent stage in the country with tests being available for certain diseases. The industry is anticipated to witness significant growth over the coming years.

Mexico point of care molecular diagnostics market will witness considerable growth over the forecast timeframe owing to the increasing focus to deliver low cost care to the patient’s home. Increasing volume of point of care molecular testing will further stimulate demand. Growing efforts to provide effective care for infectious diseases along with easy to use devices will augment industry expansion.

Some of the prominent industry players include Abbott, Sysmex, Roche, Bayer, Danaher, BioMerieux and Bio-Rad Laboratories. Presently, there are few companies operating in the industry, however, the rivalry will intensify in the coming years with the entry of new players. The industry participants adopt various strategic initiatives such as launching of new products, geographical expansion and acquisitions to consolidate their market position. For instance, in July 2017, OraSure Technologies received prequalification from WHO for its OraQuick HIV Self- Test. The company also recently entered into an agreement with Bill & Melinda Gates Foundation for reducing the price of the test in 50 developing countries. Both the aforementioned strategies would accelerate adoption and deployment of the test.

Point of Care (PoC) molecular diagnostics market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2013 to 2024, for the following segments:

Point of Care (PoC) Molecular Diagnostics Market by Technology
Polymerase Chain Reaction (PCR)
       Real Time PCR
       DNA / RNA Purification
In Situ Hybridization
Chips and Microarrays
Mass Spectrometry
Sequencing
Isothermal Amplification
Others

Point of Care (PoC) Molecular Diagnostics Market by Infectious Diseases
MRSA
Clostridium difficile
Vancomycin-resistant Enterococci
Carbapenem-Resistant Bacteria Testing
Flu
Respiratory Syncytial Virus
Candida
Tuberculosis and Drug-resistant TB
Meningitis
Gastro-intestinal Panel Testing
Chlamydia
Gonorrhea
HIV
Hepatitis C
Hepatitis B
HPV
Syphilis
Others

The above information is provided for the following regions/countries:

North America
U.S.
Canada

Europe
Germany
UK
France
Spain
Italy
Russia

Asia Pacific
Japan
China
India
South Korea
Malaysia
Thailand
Vietnam
Philippines
Australia

Latin America
Brazil
Argentina
Mexico

Middle East and Africa
South Africa
Nigeria
Egypt
Morocco
Saudi Arabia
UAE
Report Content

Chapter 1    Methodology   

1.1    Methodology   

1.1.1    Initial data exploration

1.1.2    Statistical model and forecast

1.1.3    Industry insights and validation

1.1.4    Market definition and forecast parameters

1.2    Data Sources  

1.2.1    Secondary

1.2.2    Primary

Chapter 2    Executive Summary  

2.1    PoC molecular diagnostics industry 360 degree synopsis, 2013 - 2024   

2.1.1    Business trends

2.1.2    Technology trends

2.1.3    Infectious disease trends

2.1.4    Regional trends

Chapter 3    PoC Molecular Diagnostics Industry Insights    

3.1    Industry segmentation

3.2    Industry landscape, 2013 - 2024    

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Increasing incidences of infectious diseases

3.3.1.2    Increasing R&D funding to reduce time required for molecular diagnostic tests   

3.3.1.3    Growing awareness about pre-disease diagnostics to control occurrence of diseases  

3.3.1.4    Technological advancements in DNA sequencing and analysis   

3.3.2    Industry pitfalls & challenges     

3.3.2.1    Long product development time     

3.3.2.2    Complex regulatory process   

3.4    Growth potential analysis   

3.4.1    By technology

3.4.2    By infectious diseases    

3.5    Technology landscape 

3.6    All in one diagnostics solutions overview   

3.6.1    Companies operating in all in one diagnostics   

3.6.2    Major end user types

3.6.3    Industry drivers and pitfalls 

3.6.4    Pipeline analysis   

3.7    Porter's analysis    

3.8    Competitive landscape, 2016 

3.8.1    Strategy dashboard  

3.9    PESTEL analysis     

Chapter 4    PoC Molecular Diagnostics Market, By Technology

4.1    PoC molecular diagnostics market share by technology, 2016 & 2024    

4.2    PCR (Polymerase Chain Reaction)   

4.2.1    Market size, by region, 2013-2024 (USD Million)  

4.2.2    Real time PCR

4.2.2.1    Market size, by region, 2013-2024 (USD Million)   

4.2.3    DNA/RNA purification

4.2.3.1    Market size, by region, 2013-2024 (USD Million)   

4.3    In situ hybridization   

4.3.1    Market size, by region, 2013-2024 (USD Million)  

4.4    Chips and microarrays

4.4.1    Market size, by region, 2013-2024 (USD Million)  

4.5    Mass spectrometry   

4.5.1    Market size, by region, 2013-2024 (USD Million)  

4.6    Sequencing    

4.6.1    Market size, by region, 2013-2024 (USD Million)  

4.7    Isothermal amplification   

4.7.1    Market size, by region, 2013-2024 (USD Million)  

Chapter 5   PoC Molecular Diagnostics Market, By Infectious Disease    

5.1    PoC molecular diagnostics market share by infectious disease, 2016 & 2024    

5.2    MRSA   

5.2.1    Market size, by region, 2013-2024 (USD Million)  

5.3    Clostridium difficile   

5.3.1    Market size, by region, 2013-2024 (USD Million)  

5.4    Vancomycin-resistant enterococci   

5.4.1    Market size, by region, 2013-2024 (USD Million)  

5.5    Carbapenem-resistant bacteria testing   

5.5.1    Market size, by region, 2013-2024 (USD Million)  

5.6    Flu   

5.6.1    Market size, by region, 2013-2024 (USD Million)  

5.7    Respiratory syncytial virus (RSV)    

5.7.1    Market size, by region, 2013-2024 (USD Million)  

5.8    Candida

5.8.1    Market size, by region, 2013-2024 (USD Million)  

5.9    Tuberculosis and drug-resistant TB  

5.9.1    Market size, by region, 2013-2024 (USD Million)  

5.10     Meningitis   

5.10.1    Market size, by region, 2013-2024 (USD Million)  

5.11     Gastro-intestinal panel testing     

5.11.1    Market size, by region, 2013-2024 (USD Million)  

5.12     Chlamydia   

5.12.1    Market size, by region, 2013-2024 (USD Million)  

5.13     Gonorrhea   

5.13.1    Market size, by region, 2013-2024 (USD Million)  

5.14     HIV   

5.14.1    Market size, by region, 2013-2024 (USD Million)  

5.15     Hepatitis C   

5.15.1    Market size, by region, 2013-2024 (USD Million)  

5.16     Hepatitis B   

5.16.1    Market size, by region, 2013-2024 (USD Million)  

5.17     HPV    

5.17.1    Market size, by region, 2013-2024 (USD Million)  

5.18     Syphilis 

5.18.1    Market size, by region, 2013-2024 (USD Million)  

5.19     Others  

5.19.1    Market size, by region, 2013-2024 (USD Million)  

Chapter 6   PoC Molecular Diagnostics Market, By Region

6.1    PoC molecular diagnostics market share by region, 2016 & 2024 

6.2    North America 

6.2.1    Market size, by country, 2013-2024 (USD Million)

6.2.2    Market size, by technology, 2013-2024 (USD Million)    

6.2.3    Market size, by PCR technology, 2013-2024 (USD Million)     

6.2.4    Market size, by infectious disease, 2013-2024 (USD Million)   

6.2.5    U.S.   

6.2.5.1    Market size, by technology, 2013-2024 (USD Million)   

6.2.5.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.2.5.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.2.6    Canada    

6.2.6.1    Market size, by technology, 2013-2024 (USD Million)   

6.2.6.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.2.6.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.3    Europe 

6.3.1    Market size, by country, 2013-2024 (USD Million)

6.3.2    Market size, by technology, 2013-2024 (USD Million)    

6.3.3    Market size, by PCR technology, 2013-2024 (USD Million)     

6.3.4    Market size, by infectious disease, 2013-2024 (USD Million)   

6.3.5    Germany   

6.3.5.1    Market size, by technology, 2013-2024 (USD Million)   

6.3.5.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.3.5.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.3.6    UK    

6.3.6.1    Market size, by technology, 2013-2024 (USD Million)   

6.3.6.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.3.6.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.3.7    France

6.3.7.1    Market size, by technology, 2013-2024 (USD Million)   

6.3.7.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.3.7.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.3.8    Spain 

6.3.8.1    Market size, by technology, 2013-2024 (USD Million)   

6.3.8.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.3.8.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.3.9    Italy   

6.3.9.1    Market size, by technology, 2013-2024 (USD Million)   

6.3.9.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.3.9.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.3.10    Russia

6.3.10.1    Market size, by technology, 2013-2024 (USD Million)   

6.3.10.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.3.10.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.4    Asia Pacific    

6.4.1    Market size, by country, 2013-2024 (USD Million)

6.4.2    Market size, by technology, 2013-2024 (USD Million)    

6.4.3    Market size, by PCR technology, 2013-2024 (USD Million)     

6.4.4    Market size, by infectious disease, 2013-2024 (USD Million)   

6.4.5    Japan 

6.4.5.1    Market size, by technology, 2013-2024 (USD Million)   

6.4.5.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.4.5.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.4.6    China 

6.4.6.1    Market size, by technology, 2013-2024 (USD Million)   

6.4.6.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.4.6.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.4.7    India  

6.4.7.1    Market size, by technology, 2013-2024 (USD Million)   

6.4.7.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.4.7.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.4.8    South Korea  

6.4.8.1    Market size, by technology, 2013-2024 (USD Million)   

6.4.8.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.4.8.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.4.9    Malaysia   

6.4.9.1    Market size, by technology, 2013-2024 (USD Million)   

6.4.9.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.4.9.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.4.10    Thailand   

6.4.10.1    Market size, by technology, 2013-2024 (USD Million)   

6.4.10.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.4.10.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.4.11    Vietnam   

6.4.11.1    Market size, by technology, 2013-2024 (USD Million)   

6.4.11.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.4.11.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.4.12    Philippines    

6.4.12.1    Market size, by technology, 2013-2024 (USD Million)   

6.4.12.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.4.12.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.4.13    Australia   

6.4.13.1    Market size, by technology, 2013-2024 (USD Million)   

6.4.13.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.4.13.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.5    Latin America  

6.5.1    Market size, by country, 2013-2024 (USD Million)

6.5.2    Market size, by technology, 2013-2024 (USD Million)    

6.5.3    Market size, by PCR technology, 2013-2024 (USD Million)     

6.5.4    Market size, by infectious disease, 2013-2024 (USD Million)   

6.5.5    Brazil 

6.5.5.1    Market size, by technology, 2013-2024 (USD Million)   

6.5.5.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.5.5.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.5.6    Argentina   

6.5.6.1    Market size, by technology, 2013-2024 (USD Million)   

6.5.6.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.5.6.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.5.7    Mexico

6.5.7.1    Market size, by technology, 2013-2024 (USD Million)   

6.5.7.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.5.7.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.6    MEA    

6.6.1    Market size, by country, 2013-2024 (USD Million)

6.6.2    Market size, by technology, 2013-2024 (USD Million)    

6.6.3    Market size, by PCR technology, 2013-2024 (USD Million)     

6.6.4    Market size, by infectious disease, 2013-2024 (USD Million)   

6.6.5    South Africa  

6.6.5.1    Market size, by technology, 2013-2024 (USD Million)   

6.6.5.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.6.5.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.6.6    Nigeria

6.6.6.1    Market size, by technology, 2013-2024 (USD Million)   

6.6.6.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.6.6.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.6.7    Egypt 

6.6.7.1    Market size, by technology, 2013-2024 (USD Million)   

6.6.7.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.6.7.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.6.8    Morocco   

6.6.8.1    Market size, by technology, 2013-2024 (USD Million)   

6.6.8.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.6.8.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.6.9    Saudi Arabia 

6.6.9.1    Market size, by technology, 2013-2024 (USD Million)   

6.6.9.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.6.9.3    Market size, by infectious disease, 2013-2024 (USD Million)     

6.6.10    UAE   

6.6.10.1    Market size, by technology, 2013-2024 (USD Million)   

6.6.10.2    Market size, by PCR technology, 2013-2024 (USD Million)     

6.6.10.3    Market size, by infectious disease, 2013-2024 (USD Million)     

Chapter 7   Company Profiles    

7.1    Abaxis Inc.    

7.1.1    Business overview   

7.1.2    Financial data

7.1.3    Product landscape   

7.1.4    SWOT analysis    

7.2    Abbott Laboratories   

7.2.1    Business overview   

7.2.2    Financial data

7.2.3    Product landscape   

7.2.4    Strategic outlook    

7.2.5    SWOT analysis    

7.3    Bayer Corporation   

7.3.1    Business overview   

7.3.2    Financial data

7.3.3    Product landscape   

7.3.4    SWOT analysis    

7.4    BioMerieux SA 

7.4.1    Business overview   

7.4.2    Financial data

7.4.3    Product landscape   

7.4.4    Strategic outlook    

7.4.5    SWOT analysis    

7.5    Bio-Rad Laboratories, Inc.   

7.5.1    Business overview   

7.5.2    Financial data

7.5.3    Product landscape   

7.5.4    Strategic outlook    

7.5.5    SWOT analysis    

7.6    Danaher Corporation  

7.6.1    Business overview   

7.6.2    Financial data

7.6.3    Product landscape   

7.6.4    Strategic outlook    

7.6.5    SWOT analysis    

7.7    OraSure Technologies, Inc.   

7.7.1    Business overview   

7.7.2    Financial data

7.7.3    Product landscape   

7.7.4    Strategic Outlook    

7.7.5    SWOT analysis    

7.8    Roche Diagnostics   

7.8.1    Business overview   

7.8.2    Financial data

7.8.3    Product landscape   

7.8.4    Strategic outlook    

7.8.5    SWOT analysis    

7.9    Sysmex Corporation   

7.9.1    Business overview   

7.9.2    Financial data

7.9.3    Product landscape   

7.9.4    Strategic Outlook    

7.9.5    SWOT analysis

Data Tables TABLE 1. PoC molecular diagnostics industry 360 degree synopsis, 2013 - 2024 TABLE 2. Global PoC molecular diagnostics market, 2013 - 2024 (USD Million) TABLE 3. Global PoC molecular diagnostics market, by technology, 2013 - 2024 (USD Million) TABLE 4. Global PoC molecular diagnostics market, by infectious disease, 2013 - 2024 (USD Million) TABLE 5. Global PoC molecular diagnostics market, by region, 2013 - 2024 (USD Million) TABLE 6. Industry impact forces TABLE 7. PCR (Polymerase Chain Reaction) market size, by region, 2013 - 2024 (USD Million) TABLE 8. Real time PCR market size, by region, 2013 - 2024 (USD Million) TABLE 9. DNA/RNA purification market size, by region, 2013 - 2024 (USD Million) TABLE 10. In situ hybridization market size, by region, 2013 - 2024 (USD Million) TABLE 11. Chips and microarrays market size, by region, 2013 - 2024 (USD Million) TABLE 12. Mass spectrometry market size, by region, 2013 - 2024 (USD Million) TABLE 13. Sequencing market size, by region, 2013 - 2024 (USD Million) TABLE 14. Isothermal amplification market size, by region, 2013 - 2024 (USD Million) TABLE 15. MRSA market size, by region, 2013 - 2024 (USD Million) TABLE 16. Clostridium difficile market size, by region, 2013 - 2024 (USD Million) TABLE 17. Vancomycin-resistant enterococci market size, by region, 2013 - 2024 (USD Million) TABLE 18. Carbapenem-resistant bacteria testing market size, by region, 2013 - 2024 (USD Million) TABLE 19. Flu market size, by region, 2013 - 2024 (USD Million) TABLE 20. Respiratory syncytial virus (RSV) market size, by region, 2013 - 2024 (USD Million) TABLE 21. Candida market size, by region, 2013 - 2024 (USD Million) TABLE 22. Tuberculosis and drug-resistant TB market size, by region, 2013 - 2024 (USD Million) TABLE 23. Meningitis market size, by region, 2013 - 2024 (USD Million) TABLE 24. Gastro-intestinal panel testing market size, by region, 2013 - 2024 (USD Million) TABLE 25. Chlamydia market size, by region, 2013 - 2024 (USD Million) TABLE 26. Gonorrhea market size, by region, 2013 - 2024 (USD Million) TABLE 27. HIV market size, by region, 2013 - 2024 (USD Million) TABLE 28. Hepatitis C market size, by region, 2013 - 2024 (USD Million) TABLE 29. Hepatitis B market size, by region, 2013 - 2024 (USD Million) TABLE 30. HPV market size, by region, 2013 - 2024 (USD Million) TABLE 31. Syphilis market size, by region, 2013 - 2024 (USD Million) TABLE 32. Others market size, by region, 2013 - 2024 (USD Million) TABLE 33. North America PoC molecular diagnostics market size, by country, 2013 - 2024 (USD Million) TABLE 34. North America PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 35. North America PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 36. North America PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 37. U.S. PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 38. U.S. PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 39. U.S. PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 40. Canada PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 41. Canada PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 42. Canada PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 43. Europe PoC molecular diagnostics market size, by country, 2013 - 2024 (USD Million) TABLE 44. Europe PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 45. Europe PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 46. Europe PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 47. Germany PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 48. Germany PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 49. Germany PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 50. UK PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 51. UK PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 52. UK PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 53. France PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 54. France PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 55. France PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 56. Spain PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 57. Spain PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 58. Spain PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 59. Italy PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 60. Italy PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 61. Italy PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 62. Russia PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 63. Russia PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 64. Russia PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 65. Asia Pacific PoC molecular diagnostics market size, by country, 2013 - 2024 (USD Million) TABLE 66. Asia Pacific PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 67. Asia Pacific PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 68. Asia Pacific PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 69. Japan PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 70. Japan PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 71. Japan PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 72. China PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 73. China PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 74. China PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 75. India PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 76. India PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 77. India PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 78. South Korea PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 79. South Korea PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 80. South Korea PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 81. Malaysia PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 82. Malaysia PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 83. Malaysia PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 84. Thailand PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 85. Thailand PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 86. Thailand PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 87. Vietnam PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 88. Vietnam PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 89. Vietnam PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 90. Philippines PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 91. Philippines PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 92. Philippines PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 93. Australia PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 94. Australia PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 95. Australia PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 96. Latin America PoC molecular diagnostics market size, by country, 2013 - 2024 (USD Million) TABLE 97. Latin America PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 98. Latin America PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 99. Latin America PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 100. Brazil PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 101. Brazil PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 102. Brazil PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 103. Argentina PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 104. Argentina PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 105. Argentina PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 106. Mexico PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 107. Mexico PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 108. Mexico PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 109. MEA PoC molecular diagnostics market size, by country, 2013 - 2024 (USD Million) TABLE 110. MEA PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 111. MEA PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 112. MEA PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 113. South Africa PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 114. South Africa PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 115. South Africa PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 116. Nigeria PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 117. Nigeria PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 118. Nigeria PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 119. Egypt PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 120. Egypt PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 121. Egypt PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 122. Morocco PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 123. Morocco PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 124. Morocco PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 125. Saudi Arabia PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 126. Saudi Arabia PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 127. Saudi Arabia PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) TABLE 128. UAE PoC molecular diagnostics market size, by technology, 2013 - 2024 (USD Million) TABLE 129. UAE PoC molecular diagnostics market size, by PCR technology, 2013 - 2024 (USD Million) TABLE 130. UAE PoC molecular diagnostics market size, by infectious disease, 2013 - 2024 (USD Million) Charts & Figures FIG. 1 Industry segmentation FIG. 2 Global PoC molecular diagnostics market, 2013 - 2024 (USD Million) FIG. 3 Stages of new invitro diagnostic product development FIG. 4 Growth potential analysis, by technology FIG. 5 Growth potential analysis, by infectious diseases FIG. 6 Potential addressable end users of all in one diagnostic solutions FIG. 7 Comparison of time taken in standard processing and all-in-one FIG. 8 All in one diagnostics, industry drivers and pitfalls FIG. 9 Porter's analysis FIG. 10 Strategy dashboard FIG. 11 PESTEL analysis FIG. 12 PoC molecular diagnostics market share by technology, 2016 & 2024 FIG. 13 PoC molecular diagnostics market share by infectious disease, 2016 & 2024 FIG. 14 PoC molecular diagnostics market share by region, 2016 & 2024

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Other Reports by Global Market Insights, Inc.

New Pharmaceuticals and Healthcare Reports